Liponex Shareholders Approve ImaSight Transaction
Liponex Inc. and ImaSight Inc. announced that Liponex shareholders have voted in favour of the proposed transaction with ImaSight to combine their respective businesses in accordance with the acquisition agreement that was announced March 3, 2008.
At the annual and special meeting of the Liponex shareholders, the shareholders approved the transaction, the name change from "Liponex Inc." to "ImaSight Corp." and the consolidation of Liponex's common shares on a five (5) for one (1) basis. The company expects to file articles of amendment to give effect to the consolidation and name change, conditional upon, and in connection with, the closing of the transaction with ImaSight.
Completion of the proposed transaction remains subject to the fulfillment or waiver of various conditions precedent as more particularly set forth in the acquisition agreement, including the receipt of all required third party consents and all required regulatory approvals.
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
